Jazz Pharmaceuticals plc — Director's Dealing 2022

Sep 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2022-09-07

Reporting Person: Larkin Finbar (SVP, Technical Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-07	Ordinary Shares	S	63	$150.0	Disposed	19606	Direct

Footnotes

F1: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F2: Includes 86 ordinary shares, share quantity adjusted for rounding, purchased on March 25, 2022 by Irish Pensions Trust Limited, as trustee for and on behalf of the Reporting Person, as sole beneficiary, pursuant to an Irish Revenue approved profit share scheme in transactions exempt under Rule 16b-3(c).

Also includes 121 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2022.